Skip to main content

Abstract

Surgical resection remains the only potentially curative treatment for pCC but, given the tumor anatomical position and advances stage at diagnosis, surgery is still demanding with high risk of postoperative morbidity and unsatisfactory long term outcomes.

Preoperative management of pCC patients includes biliary drainage and modulation of future liver volume, mainly by using portal vein embolization (PVE).

The type of surgical resection is related to tumor extension according to the Bismuth-Corlette classification, and in most cases is a major liver resection associated with caudate resection, extra hepatic bile duct. In addition, an adequate regional lymph-node dissection is required to achieve a curative surgery.

Extended liver resections (of more than 5 liver segments) associated with portal and/or arterial resections has been proposed to increase the radicality of surgery and improve long term results, however results of aggressive surgery are still under evaluation in Western Countries.

Among factors related with long term results, surgical margins and lymph node status are those with higher prognostic value.

An improvement of short- and long-term result of surgery for pCC is desirable, enhanced preoperative patients’ management and improvements of technical aspects of surgical resection are nowadays under evaluation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  1. Cholangiocarcinoma Working G: Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging. Dig Liver Dis. 2020;52(11):1282–1293.

    Google Scholar 

  2. Endo I, Matsuyama R, Mori R, Taniguchi K, Kumamoto T, Takeda K, Tanaka K, Kohn A, Schenk A. Imaging and surgical planning for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2014;21(8):525–32.

    Article  PubMed  Google Scholar 

  3. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet. 2005;366(9493):1303–14.

    Article  PubMed  Google Scholar 

  4. Nagino M. Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics. J Gastroenterol. 2012;47(11):1165–76.

    Article  PubMed  Google Scholar 

  5. Kimbrough CW, Cloyd JM, Pawlik TM. Surgical approaches for the treatment of perihilar cholangiocarcinoma. Expert Rev Anticancer Ther. 2018;18(7):673–83.

    Article  CAS  PubMed  Google Scholar 

  6. Mizuno T, Ebata T, Nagino M. Advanced hilar cholangiocarcinoma: an aggressive surgical approach for the treatment of advanced hilar cholangiocarcinoma: perioperative management, extended procedures, and multidisciplinary approaches. Surg Oncol. 2020;33:201–6.

    Article  PubMed  Google Scholar 

  7. Braga M, Gianotti L, Nespoli L, Radaelli G, Di Carlo V. Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg. 2002;137(2):174–80.

    Article  PubMed  Google Scholar 

  8. Lee DH, Kim B, Lee ES, Kim HJ, Min JH, Lee JM, Choi MH, Seo N, Choi SH, Kim SH, et al. Radiologic evaluation and structured reporting form for extrahepatic bile duct cancer: 2019 consensus recommendations from the Korean Society of abdominal radiology. Korean J Radiol. 2021;22(1):41–62.

    Article  PubMed  Google Scholar 

  9. Nuzzo G, Giuliante F, Ardito F, Giovannini I, Aldrighetti L, Belli G, Bresadola F, Calise F, Dalla Valle R, D'Amico DF, et al. Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg. 2012;147(1):26–34.

    Article  PubMed  Google Scholar 

  10. Farges O, Regimbeau JM, Fuks D, Le Treut YP, Cherqui D, Bachellier P, Mabrut JY, Adham M, Pruvot FR, Gigot JF. Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg. 2013;100(2):274–83.

    Article  CAS  PubMed  Google Scholar 

  11. Iacono C, Ruzzenente A, Campagnaro T, Bortolasi L, Valdegamberi A, Guglielmi A. Role of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection: highlights and drawbacks. Ann Surg. 2013;257(2):191–204.

    Article  PubMed  Google Scholar 

  12. Komaya K, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Yamaguchi J, Nagino M. Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: a propensity score matching analysis of resectable perihilar cholangiocarcinoma. Surgery. 2017;161(2):394–404.

    Article  PubMed  Google Scholar 

  13. Wiggers JK, Groot Koerkamp B, Coelen RJ, Doussot A, van Dieren S, Rauws EA, Schattner MA, van Lienden KP, Brown KT, Besselink MG, et al. Percutaneous preoperative biliary drainage for resectable perihilar cholangiocarcinoma: no association with survival and no increase in seeding metastases. Ann Surg Oncol. 2015;22(Suppl 3):S1156–63.

    Article  PubMed  Google Scholar 

  14. Coelen RJS, Roos E, Wiggers JK, Besselink MG, Buis CI, Busch ORC, Dejong CHC, van Delden OM, van Eijck CHJ, Fockens P, et al. Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial. Lancet Gastroenterol Hepatol. 2018;3(10):681–90.

    Article  PubMed  Google Scholar 

  15. Maeda T, Ebata T, Yokoyama Y, Mizuno T, Yamaguchi J, Onoe S, Watanabe N, Kawashima H, Nagino M. Preoperative course of patients undergoing endoscopic nasobiliary drainage during the management of resectable perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2019;26(8):341–7.

    PubMed  Google Scholar 

  16. Guglielmi A, Ruzzenente A, Conci S, Valdegamberi A, Iacono C. How much remnant is enough in liver resection? Dig Surg. 2012;29(1):6–17.

    Article  PubMed  Google Scholar 

  17. Olthof PB, Aldrighetti L, Alikhanov R, Cescon M, Groot Koerkamp B, Jarnagin WR, Nadalin S, Pratschke J, Schmelze M, Sparrelid E, et al. Portal vein embolization is associated with reduced liver failure and mortality in high-risk resections for perihilar cholangiocarcinoma. Ann Surg Oncol. 2020;27(7):2311–8.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Olthof PB, Coelen RJS, Wiggers JK, Groot Koerkamp B, Malago M, Hernandez-Alejandro R, Topp SA, Vivarelli M, Aldrighetti LA, Robles Campos R, et al. High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry. HPB (Oxford). 2017;19(5):381–7.

    Article  Google Scholar 

  19. Cholangiocarcinoma Working G: Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part II: Treatment. Dig Liver Dis. 2020;52(12):1430–1442.

    Google Scholar 

  20. Melekhina O, Efanov M, Alikhanov R, Tsvirkun V, Kulezneva Y, Kazakov I, Vankovich A, Koroleva A, Khatkov I. Percutaneous radiofrequency-assisted liver partition versus portal vein embolization before hepatectomy for perihilar cholangiocarcinoma. BJS Open. 2020;4(1):101–8.

    Article  CAS  PubMed  Google Scholar 

  21. de Santibanes E, Alvarez FA, Ardiles V, Pekolj J, de Santibanes M. Inverting the ALPPS paradigm by minimizing first stage impact: the Mini-ALPPS technique. Langenbeck’s Arch Surg. 2016;401(4):557–63.

    Article  Google Scholar 

  22. Rassam F, Roos E, van Lienden KP, van Hooft JE, Klumpen HJ, van Tienhoven G, Bennink RJ, Engelbrecht MR, Schoorlemmer A, Beuers UHW, et al. Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience. Langenbeck’s Arch Surg. 2018;403(3):289–307.

    Article  CAS  Google Scholar 

  23. Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258(1):129–40.

    Article  PubMed  Google Scholar 

  24. Miyazaki M, Kimura F, Shimizu H, Yoshidome H, Otsuka M, Kato A, Hideyuki Y, Nozawa S, Furukawa K, Mituhashi N, et al. Extensive hilar bile duct resection using a transhepatic approach for patients with hepatic hilar bile duct diseases. Am J Surg. 2008;196(1):125–9.

    Article  PubMed  Google Scholar 

  25. Chen RX, Li CX, Luo CH, Zhang H, Zhou T, Wu XF, Wang XH, Li XC. Surgical strategies for the treatment of bismuth type I and II Hilar cholangiocarcinoma: bile duct resection with or without hepatectomy? Ann Surg Oncol. 2020;27(9):3374–82.

    Article  PubMed  Google Scholar 

  26. Uesaka K. Left hepatectomy or left trisectionectomy with resection of the caudate lobe and extrahepatic bile duct for hilar cholangiocarcinoma (with video). J Hepatobiliary Pancreat Sci. 2012;19(3):195–202.

    Article  PubMed  Google Scholar 

  27. Bismuth H. Surgical anatomy and anatomical surgery of the liver. World J Surg. 1982;6(1):3–9.

    Article  CAS  PubMed  Google Scholar 

  28. Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S: Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg. 1990;14(4):535–543; discussion 544.

    Google Scholar 

  29. Zhang XF, Beal EW, Chakedis J, Chen Q, Lv Y, Ethun CG, Salem A, Weber SM, Tran T, Poultsides G, et al. Defining early recurrence of hilar cholangiocarcinoma after curative-intent surgery: a multi-institutional study from the US extrahepatic biliary malignancy consortium. World J Surg. 2018;42(9):2919–29.

    Article  PubMed  Google Scholar 

  30. Neuhaus P, Thelen A, Jonas S, Puhl G, Denecke T, Veltzke-Schlieker W, Seehofer D. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol. 2012;19(5):1602–8.

    Article  PubMed  Google Scholar 

  31. Tamoto E, Hirano S, Tsuchikawa T, Tanaka E, Miyamoto M, Matsumoto J, Kato K, Shichinohe T. Portal vein resection using the no-touch technique with a hepatectomy for hilar cholangiocarcinoma. HPB (Oxford). 2014;16(1):56–61.

    Article  Google Scholar 

  32. Nagino M. Fifty-year history of biliary surgery. Ann Gastroenterol Surg. 2019;3(6):598–605.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Chen W, Ke K, Chen YL. Combined portal vein resection in the treatment of hilar cholangiocarcinoma: a systematic review and meta-analysis. Eur J Surg Oncol. 2014;40(5):489–95.

    Article  CAS  PubMed  Google Scholar 

  34. Mizuno T, Ebata T, Yokoyama Y, Igami T, Yamaguchi J, Onoe S, Watanabe N, Kamei Y, Nagino M: Combined vascular resection for locally advanced perihilar cholangiocarcinoma. Ann Surg. 2020.

    Google Scholar 

  35. Komaya K, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Yamaguchi J, Nagino M. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach. Surgery. 2018;163(4):732–8.

    Article  PubMed  Google Scholar 

  36. Zhang XF, Squires MH 3rd, Bagante F, Ethun CG, Salem A, Weber SM, Tran T, Poultsides G, Son AY, Hatzaras I, et al. The impact of intraoperative re-resection of a positive bile duct margin on clinical outcomes for Hilar cholangiocarcinoma. Ann Surg Oncol. 2018;25(5):1140–9.

    Article  PubMed  Google Scholar 

  37. Shingu Y, Ebata T, Nishio H, Igami T, Shimoyama Y, Nagino M. Clinical value of additional resection of a margin-positive proximal bile duct in hilar cholangiocarcinoma. Surgery. 2010;147(1):49–56.

    Article  PubMed  Google Scholar 

  38. Matthaei H, Lingohr P, Strasser A, Dietrich D, Rostamzadeh B, Glees S, Roering M, Mohring P, Scheerbaum M, Stoffels B, et al. Biliary intraepithelial neoplasia (BilIN) is frequently found in surgical margins of biliary tract cancer resection specimens but has no clinical implications. Virchows Arch. 2015;466(2):133–41.

    Article  CAS  PubMed  Google Scholar 

  39. Otsuka S, Ebata T, Yokoyama Y, Mizuno T, Tsukahara T, Shimoyama Y, Ando M, Nagino M. Clinical value of additional resection of a margin-positive distal bile duct in perihilar cholangiocarcinoma. Br J Surg. 2019;106(6):774–82.

    Article  CAS  PubMed  Google Scholar 

  40. Sasaki R, Takeda Y, Funato O, Nitta H, Kawamura H, Uesugi N, Sugai T, Wakabayashi G, Ohkohchi N. Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. World J Surg. 2007;31(9):1788–96.

    Article  PubMed  Google Scholar 

  41. Shinohara K, Ebata T, Shimoyama Y, Mizuno T, Yokoyama Y, Yamaguchi J, Onoe S, Watanabe N, Nagino M. A study on radial margin status in resected perihilar cholangiocarcinoma. Ann Surg. 2021;273(3):572–8.

    Article  PubMed  Google Scholar 

  42. Endo I, Hirahara N, Miyata H, Yamamoto H, Matsuyama R, Kumamoto T, Homma Y, Mori M, Yasuyuki S, Wakabayashi G et al. Mortality, morbidity and failure to rescue in hepatopancreatoduodenectomy: an analysis of 422 patients registered in the National Clinical Database in Japan. J Hepatobiliary Pancreat Sci. 2021.

    Google Scholar 

  43. Guglielmi A, Ruzzenente A, Bertuzzo F, Iacono C. Assessment of nodal status for perihilar cholangiocarcinoma location, number, or ratio of involved nodes. Hepatobiliary Surg Nutr. 2013;2(5):281–3.

    PubMed  PubMed Central  Google Scholar 

  44. Bagante F, Tran T, Spolverato G, Ruzzenente A, Buttner S, Ethun CG, Groot Koerkamp B, Conci S, Idrees K, Isom CA, et al. Perihilar cholangiocarcinoma: number of nodes examined and optimal lymph node prognostic scheme. J Am Coll Surg. 2016;222(5):750–759 e752.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Chun YS, Pawlik TM, Vauthey JN. 8th Edition of the AJCC cancer staging manual: pancreas and hepatobiliary cancers. Ann Surg Oncol. 2018;25(4):845–7.

    Article  PubMed  Google Scholar 

  46. Ruzzenente A, Bagante F, Ardito F, Campagnaro T, Scoleri I, Conci S, Iacono C, Giuliante F, Guglielmi A. Comparison of the 7th and 8th editions of the American Joint Committee on Cancer Staging Systems for perihilar cholangiocarcinoma. Surgery. 2018;164(2):244–50.

    Article  PubMed  Google Scholar 

  47. Franken LC, van der Poel MJ, Latenstein AEJ, Zwart MJ, Roos E, Busch OR, Besselink MG, van Gulik TM. Minimally invasive surgery for perihilar cholangiocarcinoma: a systematic review. J Robot Surg. 2019;13(6):717–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Ratti F, Fiorentini G, Cipriani F, Catena M, Paganelli M, Aldrighetti L. Perihilar cholangiocarcinoma: are we ready to step towards minimally invasiveness? Updat Surg. 2020;72(2):423–33.

    Article  Google Scholar 

  49. Franken LC, Schreuder AM, Roos E, van Dieren S, Busch OR, Besselink MG, van Gulik TM. Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: a systematic review and meta-analysis. Surgery. 2019;165(5):918–28.

    Article  PubMed  Google Scholar 

  50. Bagante F, Ruzzenente A, Beal EW, Campagnaro T, Merath K, Conci S, Akgul O, Alexandrescu S, Marques HP, Lam V, et al. Complications after liver surgery: a benchmark analysis. HPB (Oxford). 2019;21(9):1139–49.

    Article  Google Scholar 

  51. Tang Z, Yang Y, Zhao Z, Wei K, Meng W, Li X. The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: a systematic review and meta-analysis. Medicine (Baltimore). 2018;97(34):e11999.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alfredo Guglielmi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bagante, F., Tripepi, M., Guglielmi, A., Iacono, C., Ruzzenente, A. (2022). Major Hepatic Resection for Peri-hilar Biliary Cancers. In: Makuuchi, M., et al. The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-19-0063-1_56

Download citation

  • DOI: https://doi.org/10.1007/978-981-19-0063-1_56

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-19-0062-4

  • Online ISBN: 978-981-19-0063-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics